CD33 and Decreased total neutrophil count: GO administration for consolidation after reduced-intensity conditioning and AHSCT in a pediatric cohort with CD33+ AML noted severe neutropenia in all 14 patients (100%), but no IFDs have been documented (under prophylaxis; one death due to progressive disease and respiratory syncytial virus infection) [129].